Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma

Clinical trial NCT02175771 · COMPLETED

Trial details

NCT number: NCT02175771
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Persistent Asthma

Start date: 2014-07-01
Primary completion: 2015-07-01
Enrollment: 758

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.